ArticleBiomedicines2022

In Model, In Vitro and In Vivo Killing Efficacy of Antitumor Peptide RDP22 on MUG-Mel2, a Patient Derived Cell Line of an Aggressive Melanoma Metastasis.

Maximiliane Wußmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.